jun ling li - Search Results

Year	Number of Results
2002	1
2003	2
2004	2
2005	1
2006	1
2007	1
2008	1
2010	2
2011	7
2012	7
2013	4
2014	6
2015	5
2016	2
2017	1
2018	3
2019	7
2020	1
2021	2
2022	7
2023	2
2024	2

1

Effects of electroacupuncture on mitophagy mediated by SIRT3/PINK1/Parkin pathway in Parkinson's disease mice.

Zhang GJ, Wang Y, Li JL, Ma J, Wang YC. Zhang GJ, et al. Among authors: li jl. Zhen Ci Yan Jiu. 2024 Mar 25;49(3):221-230. doi: 10.13702/j.1000-0607.20230654. Zhen Ci Yan Jiu. 2024. PMID: 38500318 Chinese, English.

2

Influence of PD-L1 expression on the efficacy of EGFR-TKIs in EGFR-mutant non-small cell lung cancer.

Lei SY, Xu HY, Li HS, Yang YN, Xu F, Li JL, Wang ZJ, Xing PY, Hao XZ, Wang Y. Lei SY, et al. Among authors: li jl. Thorac Cancer. 2023 Aug;14(24):2327-2337. doi: 10.1111/1759-7714.15021. Epub 2023 Jul 5. Thorac Cancer. 2023. PMID: 37407282 Free PMC article.

3

Corrigendum to "Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/ NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis" [J. Ethnopharmacol. 217 (2018) 36-48].

Zhao PY, Wang YQ, Liu XH, Zhu YJ, Zhao H, Zhang QX, Qi F, Li JL, Zhang N, Fan YP, Li KN, Zhao YY, Lei JF, Wang L. Zhao PY, et al. Among authors: li jl. J Ethnopharmacol. 2024 Jan 10;318(Pt A):116853. doi: 10.1016/j.jep.2023.116853. Epub 2023 Jun 29. J Ethnopharmacol. 2024. PMID: 37393125 No abstract available.

4

SmDXS5, acting as a molecular valve, plays a key regulatory role in the primary and secondary metabolism of tanshinones in Salvia miltiorrhiza.

Zhang DC, Luo LL, Wang ZR, Xu WJ, Li JL, Tan ST, Wu JH, Li Y, Zhang C, Liang C, Wang XY. Zhang DC, et al. Among authors: li jl. Front Plant Sci. 2022 Nov 10;13:1043761. doi: 10.3389/fpls.2022.1043761. eCollection 2022. Front Plant Sci. 2022. PMID: 36438137 Free PMC article.

5

Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review.

Li HS, Lei SY, Li JL, Xing PY, Hao XZ, Xu F, Xu HY, Wang Y. Li HS, et al. Among authors: li jl. Front Immunol. 2022 Aug 29;13:908436. doi: 10.3389/fimmu.2022.908436. eCollection 2022. Front Immunol. 2022. PMID: 36105807 Free PMC article.

6

Bu Shen Yi Sui Capsule Promotes Myelin Repair by Modulating the Transformation of A1/A2 Reactive Astrocytes In Vivo and In Vitro.

Zha Z, Liu YJ, Liu SS, Zhang N, Li JL, Qi F, Jin LY, Xue B, Yang T, Fan YP, Zhao H, Wang L. Zha Z, et al. Among authors: li jl. Oxid Med Cell Longev. 2022 Sep 1;2022:3800004. doi: 10.1155/2022/3800004. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36092158 Free PMC article.

7

Study on the Anti-demyelination Mechanism of Bu-Shen-Yi-Sui Capsule in the Central Nervous System Based on Network Pharmacology and Experimental Verification.

Zha Z, Liu YJ, Liu SS, Zhang N, Li JL, Qi F, Jin LY, Xue B, Yang T, Fan YP, Zhao H, Wang L. Zha Z, et al. Among authors: li jl. Mediators Inflamm. 2022 Jul 12;2022:9241261. doi: 10.1155/2022/9241261. eCollection 2022. Mediators Inflamm. 2022. PMID: 35865997 Free PMC article.

8

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.

Li HS, Yang GJ, Cai Y, Li JL, Xu HY, Zhang T, Zhou LQ, Wang YY, Wang JL, Hu XS, Yan X, Wang Y. Li HS, et al. Among authors: li jl. Front Pharmacol. 2022 Jun 13;13:919652. doi: 10.3389/fphar.2022.919652. eCollection 2022. Front Pharmacol. 2022. PMID: 35770100 Free PMC article.

9

Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study.

Li HS, Li JL, Yan X, Xu HY, Zhou LQ, Hu XS, Wang YY, Lei SY, Wang Y. Li HS, et al. Among authors: li jl. J Thorac Dis. 2022 May;14(5):1428-1440. doi: 10.21037/jtd-21-1841. J Thorac Dis. 2022. PMID: 35693621 Free PMC article.

10

Bu Shen Yi Sui Capsules Promote Remyelination by Regulating MicroRNA-219 and MicroRNA-338 in Exosomes to Promote Oligodendrocyte Precursor Cell Differentiation.

Ji J, Sun YQ, Zha Z, Xue B, Li JL, Jin LY, Qi F, Zhang N, Zhao H, Fan YP, Wang L. Ji J, et al. Among authors: li jl. Evid Based Complement Alternat Med. 2022 Apr 13;2022:3341481. doi: 10.1155/2022/3341481. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35463062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year